Mometasona Viatris (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Viatris, is a corticosteroid presented as a topical formulation for skin use. It is indicated for the treatment of various inflammatory dermatoses in adults and children when prescribed by a healthcare professional.

GNH USA supplies Mometasona Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasona Viatris is a topical corticosteroid used to manage inflammatory skin disorders.

Psoriasis: reduces plaque thickness and erythema. Atopic dermatitis: alleviates itching and inflammation. Contact dermatitis: diminishes redness and swelling. Seborrheic dermatitis: controls scaling and irritation. Other inflammatory skin conditions: provides anti‑inflammatory relief.

Mometasona Viatris may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging at the application site - Itching or mild irritation - Dryness or flaking of the skin - Redness or erythema - Folliculitis or acne‑like eruptions - Pruritus worsening after prolonged use

Serious or Rare Side Effects: - Skin atrophy or thinning - Secondary bacterial, fungal or viral infection - Adrenal suppression with extensive use - Allergic contact dermatitis - Hypercortisolism symptoms - Delayed wound healing

Before initiating therapy, consider the following safety measures.

Assess severity: limit use to mild‑moderate conditions. Avoid prolonged use: discontinue after recommended period. Do not apply to infected or ulcerated skin. Use minimal effective amount: apply a thin layer. Avoid occlusion unless directed by a clinician. Store at room temperature: keep in the original container, protect from moisture and light.

Topical corticosteroids can interact with other agents, affecting efficacy or safety.

Major Interactions (Avoid):\n- Systemic corticosteroids: may increase systemic glucocorticoid exposure. - Potent CYP3A4 inhibitors: could raise local drug concentration. - Antifungal agents (e.g., azoles): risk of enhanced irritation.

Moderate Interactions (Monitor Closely): - Topical antibiotics: monitor for combined irritation. - Other topical steroids: risk of additive immunosuppression. - Skin moisturizers or emollients: may alter absorption profile.